Basics Exagen Inc. IPO Date: September 20, 2019 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $163.17M Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.69% Avg Daily Range (30 D): $0.21 | 2.39% Avg Daily Range (90 D): $0.17 | 1.86% Institutional Daily Volume Avg Daily Volume: .06M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 68 Avg Inst. Trade: $1.75M Avg Inst. Trade (30 D): $1.15M Avg Inst. Trade (90 D): $2.73M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.21M Avg Closing Trade (30 D): $8.04M Avg Closing Trade (90 D): $4.57M Avg Closing Volume: 190.44K     News Nov 11, 2025 @ 2:00 PM Exagen Inc. to Participate in Fourth Quarter Inves... Source: Ryan Douglas Jun 13, 2024 @ 12:50 PM Why Fast-paced Mover Exagen (XGN) Is a Great Choic... Source: Zacks Equity Research Jun 10, 2024 @ 12:03 PM Time to Play 5 Top-Ranked Stocks With Rising P/E? Source: Sanghamitra Saha May 13, 2024 @ 1:10 PM Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Es... Source: Zacks Equity Research May 7, 2024 @ 9:10 PM Quanterix Corporation (QTRX) Reports Q1 Loss, Tops... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.92 $-.31 $-.21 Diluted EPS $-.92 $-.31 $-.21 Revenue $ 63.6M $ 17.24M $ 17.2M Gross Profit $ 38.07M $ 10.08M $ 10.4M Net Income / Loss $ -19.04M $ -7.09M $ -4.44M Operating Income / Loss $ -12.48M $ -3.1M $ -2.63M Cost of Revenue $ 25.53M $ 7.17M $ 6.81M Net Cash Flow $ 13.62M $ 5.62M $ 18.84M PE Ratio